November 11, 2021
The use of stimulant drugs is a growing issue and continues to pose major challenges to health and justice systems across the world.1
Stimulants include a range of natural and synthetic drugs that speed up messages between the brain and body, making a person feel more awake, alert, confident or energetic.2
Some commonly used stimulants are:
Stimulant use (particularly heavy use) is associated with a range of harms, including:
The recognition of these harms has led to an emphasis on improving access to evidence-based treatments4 – particularly for cocaine and amphetamines.1
Cocaine and amphetamines are the main focus of stimulant treatment research, due to the large number of people who use them globally and the serious harms they can cause.1
(Note: while nicotine is more widely used than cocaine and amphetamines and is also very harmful, it is not currently the priority focus for treatment research as we already know the best available treatments.)
One of the shortcomings of stimulant treatment is that there are no effective pharmacotherapy medications available yet.3
Pharmacotherapy involves replacing a drug of dependence with a legally-prescribed substitute to help reduce withdrawal symptoms, drug cravings and the likelihood of use.5
For example, methadone and buprenorphine are used in opioid pharmacotherapy to treat opioid dependence.
Similarly, alcohol dependence is often treated with naltrexone and acomprosate.
Usually, these medications are combined with therapy/counselling as part of a comprehensive treatment plan.6, 7
Pharmacotherapy doesn’t suit everyone – but there’s strong evidence showing the effectiveness of it as a first-line treatment.7, 8
Although pharmacotherapy medications are not currently approved to treat cocaine or amphetamine use, research is continuing and some trials are showing promising results.9, 10
In the meantime, specialised treatments for stimulant use typically involve psychosocial interventions, such as:
Psychosocial intervention can achieve good results, particularly if the person is ready to make a change.3 However, evidence suggests that none of the interventions are significantly better than the others at reducing stimulant use – except for contingency management.1, 3, 4, 14, 15
But, this treatment is rarely used in Australia.
Contingency management (CM) is based on the idea that if a desired behaviour is reinforced and rewarded, it is more likely to continue.16
For example, drug taking is monitored through urine screening, and if no substance is detected the person is provided with a reward or incentive.1
The three key principles of CM are:
Aside from reducing drug use, other encouraged behaviours might include attendance at treatment sessions or taking prescribed medications for other health conditions.18
In the U.S, where contingency management is more common, a variety of reward options are used:
An example of a monetary reward system for contingency management could look something like this3:
(Note: when a person returns a positive sample, the reward accumulation resets back to 0)
A number of reviews have found contingency management leads to a significant reduction in stimulant use (particularly when combined with a psychosocial therapy like CBT) and is more effective than a single psychosocial intervention alone or treatment as usual.1, 4, 14
In Australia, contingency management is poorly understood and rarely used in practice, despite strong evidence of success elsewhere.17
It’s also attracted opposition from service planners, clinicians, and communities,1 for reasons such as:
Another concern is that CM doesn’t address any of the underlying causes that contribute to substance use – such as unemployment, mental illness, trauma, housing insecurity or homelessness, and poverty.19
However, evidence has suggested combining contingency management with other therapies, like a community reinforcement approach or cognitive behavioural therapy, could make it more effective and would address some of the concerns listed above. 1, 14, 21
Another approach is to focus on reducing the harms from stimulant use – rather than just reducing stimulant use.1
Mental health and harm reduction interventions can help, for example:
Although the currently available psychosocial interventions don’t have a particularly strong effect on reducing stimulant use, they can be really effective in reducing some of these harms22 – which is often just as important.
Ultimately, we should be willing to trial any proven treatment approaches that show effectiveness to help people recover better.
Not sure what you are looking for? Try our intuitive Path2Help tool and be matched with support information and services tailored to you.
Other articles about treatment
Last updated: 11 Nov 2021
Subscribe to receive ADF News updates:
The ADF acknowledges the Traditional Custodians of the lands across Australia upon which we work. We recognise the continued connection of First Nations people to the land, the waterways and to community and kin, and pay respects to Elders past, present and emerging.
Alcohol and Drug Foundation’s services are here to support communities across all states and territories. We welcome everyone to our service.
This site complies with the HONcode standard for trustworthy health information:
Website by Liquorice